复方醒脑液治疗颅脑损伤后综合征的临床观察  

Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome

作　　者：钟秀均 黄书岚[1] 

机构地区：[1]武汉大学人民医院神经外科,武汉430060

出　　处：《中国临床神经外科杂志》2016年第5期278-280,共3页Chinese Journal of Clinical Neurosurgery

摘　　要：目的观察复方醒脑液治疗颅脑损伤后综合征（PTBS）的疗效。方法2011～2015年收治PTBS80例，其中40例给予西医常规治疗（对照组），40例在对照组基础上口服复方醒脑液（观察组；每次50ml，每日2次）。采用临床疗效及90项症状清单（SCL-90）评分评估复方醒脑液治疗PTBS的效果。结果观察组临床治愈2例，显效15例，好转10例，无效13例；对照组显效4例，好转10例，无效26例；观察组总有效率（67．5％，27／40）明显高于对照组（35．0％，14／40；P〈0．05）。治疗后，观察组SCL-90总分、躯体化评分、人际关系敏感评分较治疗前均明显降低（P〈0．05）；而且，明显低于对照组治疗后的评分（P〈0．05）。结论复方醒脑液具有减轻PTBS头痛、眩晕等症候群的作用；用药后躯体症状、人际关系敏感改善明显，对睡眠、饮食也有所改善。Objective To observe the curative effect of compound decoction for cerebral prorection （CDCP） on post-traumatic brain syndrome. Methods The clinical data of 80 patients with post-traumatic brain syndrome, of whom, 40 received conventional treatment （control group） and 40 received CDCP expect the conventional treatment （observed group）. The symptom cheklist 90 （SCL-90） score was used to assessed curative effect. Results The effective rate [67.5%（27/40）] was significantly higher in observed group than that [35.0% （14/40）] in control group （P〈0.01）. The total score [（170.21 ±21.62） points], body score [（2.06±0.41） points], interpersonal sensitivity score [（2.03±0.24） points] of SCL-90 were significantly lower in observed group than those [（187.51 ±28.54） points, （2.39± 0.31） points, （2.36±0.34） points, respectively] in control group （P〈0.05）. Conclusion The curative effects of CDCP on the post-traumatic brain syndrome are good, including relieving headache, dizziness and other symptoms.

关 键 词：颅脑损伤 颅脑损伤后综合征 复方醒脑液 临床疗效 

分 类 号：R651.15[医药卫生—外科学]